These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 18192069)

  • 41. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account.
    Ingel K; Jahn-Eimermacher A
    Biom J; 2014 Jul; 56(4):631-48. PubMed ID: 24817598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sequential analysis in clinical and epidemiological research].
    van der Tweel I; Schipper M
    Ned Tijdschr Geneeskd; 2002 Dec; 146(49):2348-52. PubMed ID: 12510397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation in flexible two stage designs.
    Brannath W; König F; Bauer P
    Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigating maximum power losses in survival studies with nonstratified randomization.
    Palta M
    Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of conditional and unconditional randomization tests for highly stratified designs.
    Flyer PA
    Biometrics; 1998 Dec; 54(4):1551-9. PubMed ID: 9883551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adaptive designs: looking for a needle in the haystack-a new challenge in medical research.
    Bauer P
    Stat Med; 2008 May; 27(10):1565-80. PubMed ID: 17935261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal two-stage design for a series of pilot trials of new agents.
    Yao TJ; Venkatraman ES
    Biometrics; 1998 Sep; 54(3):1183-9. PubMed ID: 9750258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimating sample size in clinical studies: basic methodological principles.
    Carneiro AV
    Rev Port Cardiol; 2003 Dec; 22(12):1513-21. PubMed ID: 15008067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
    Nie L; Chu H; Cole SR
    Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The advantages and disadvantages of adaptive designs for clinical trials.
    Bauer P; Brannath W
    Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of two methods for adaptive interim analyses in clinical trials.
    Wassmer G
    Biometrics; 1998 Jun; 54(2):696-705. PubMed ID: 9629649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small-sample performance of the robust score test and its modifications in generalized estimating equations.
    Guo X; Pan W; Connett JE; Hannan PJ; French SA
    Stat Med; 2005 Nov; 24(22):3479-95. PubMed ID: 15977302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
    Friede T; Mitchell C; Müller-Velten G
    Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adaptive statistical analysis following sample size modification based on interim review of effect size.
    Hung HM; Cui L; Wang SJ; Lawrence J
    J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlling test size while gaining the benefits of an internal pilot design.
    Coffey CS; Muller KE
    Biometrics; 2001 Jun; 57(2):625-31. PubMed ID: 11414593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.